文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

CRISPR 激活和干扰筛选解码原代人 T 细胞的刺激反应。

CRISPR activation and interference screens decode stimulation responses in primary human T cells.

机构信息

Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA 94158, USA.

Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.

出版信息

Science. 2022 Feb 4;375(6580):eabj4008. doi: 10.1126/science.abj4008.


DOI:10.1126/science.abj4008
PMID:35113687
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9307090/
Abstract

Regulation of cytokine production in stimulated T cells can be disrupted in autoimmunity, immunodeficiencies, and cancer. Systematic discovery of stimulation-dependent cytokine regulators requires both loss-of-function and gain-of-function studies, which have been challenging in primary human cells. We now report genome-wide CRISPR activation (CRISPRa) and interference (CRISPRi) screens in primary human T cells to identify gene networks controlling interleukin-2 (IL-2) and interferon-γ (IFN-γ) production. Arrayed CRISPRa confirmed key hits and enabled multiplexed secretome characterization, revealing reshaped cytokine responses. Coupling CRISPRa screening with single-cell RNA sequencing enabled deep molecular characterization of screen hits, revealing how perturbations tuned T cell activation and promoted cell states characterized by distinct cytokine expression profiles. These screens reveal genes that reprogram critical immune cell functions, which could inform the design of immunotherapies.

摘要

在自身免疫、免疫缺陷和癌症中,刺激 T 细胞产生细胞因子的调节可能会被打乱。系统地发现依赖于刺激的细胞因子调节剂需要进行功能丧失和功能获得研究,这在原代人细胞中具有挑战性。我们现在报告了在原代人 T 细胞中进行的全基因组 CRISPR 激活 (CRISPRa) 和干扰 (CRISPRi) 筛选,以鉴定控制白细胞介素-2 (IL-2) 和干扰素-γ (IFN-γ) 产生的基因网络。排列的 CRISPRa 证实了关键的命中,并实现了多路分泌组学特征,揭示了重塑的细胞因子反应。将 CRISPRa 筛选与单细胞 RNA 测序相结合,能够深入分子表征筛选命中,揭示了扰动如何调整 T 细胞激活并促进以不同细胞因子表达谱为特征的细胞状态。这些筛选揭示了可重新编程关键免疫细胞功能的基因,这可能为免疫疗法的设计提供信息。

相似文献

[1]
CRISPR activation and interference screens decode stimulation responses in primary human T cells.

Science. 2022-2-4

[2]
Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function.

Cell. 2018-11-15

[3]
Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1.

Blood. 1997-10-1

[4]
Activation of a human T cell line: a two-stimulus requirement in the pretranslational events involved in the coordinate expression of interleukin 2 and gamma-interferon genes.

J Immunol. 1985-3

[5]
Antithrombin III inhibits lymphocyte proliferation, immunoglobulin production and mRNA expression of lymphocyte growth factors (IL-2, gamma-IFN and IL-4) in vitro.

Transpl Immunol. 2001-10

[6]
Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.

Cancer J Sci Am. 2000-2

[7]
IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells.

J Immunol. 2000-8-15

[8]
Selective modulation of IFN-gamma mRNA stability by IL-12/NKSF.

Cell Immunol. 1994-12

[9]
Kinetics of cytokine and NFAT gene expression in human interleukin-2-dependent T lymphoblasts stimulated via T-cell receptor.

Immunology. 1998-3

[10]
Interleukin-12 differentially regulates expression of IFN-gamma and interleukin-2 in human T lymphoblasts.

J Interferon Cytokine Res. 2000-10

引用本文的文献

[1]
CRISPR tools for T cells: targeting the genome, epigenome, and transcriptome.

Trends Cancer. 2025-8-28

[2]
Characterization of cis-regulatory elements and functional variants in colorectal cancer using epigenomics and CRISPRi screenings.

Nat Cancer. 2025-8-25

[3]
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency.

Cancer Cell. 2025-8-18

[4]
CRISPRi Screening Identifies SON and MAP4K1 as Regulators of Type III Cytokine Expression in Innate Lymphoid Cells.

bioRxiv. 2025-8-15

[5]
Comprehensive transcription factor perturbations recapitulate fibroblast transcriptional states.

Nat Genet. 2025-8-6

[6]
Allogeneic CAR-engineered cellular therapy for relapsed and refractory large B cell lymphoma: a systematic review and meta-analysis.

Front Immunol. 2025-7-8

[7]
CRISPR/Cas9 technology in tumor research and drug development application progress and future prospects.

Front Pharmacol. 2025-7-8

[8]
Closing the loop: Teaching single-cell foundation models to learn from perturbations.

bioRxiv. 2025-7-12

[9]
Epigenome Engineering Using dCas Systems for Biomedical Applications and Biotechnology: Current Achievements, Opportunities and Challenges.

Int J Mol Sci. 2025-7-2

[10]
Molecular crosstalk in perivascular adipose tissue: mechanisms of inflammation, metabolic dysregulation, and therapeutic opportunities in cardiovascular disease.

Front Cardiovasc Med. 2025-6-26

本文引用的文献

[1]
Systematic discovery and perturbation of regulatory genes in human T cells reveals the architecture of immune networks.

Nat Genet. 2022-8

[2]
A Single-Cell Transcriptomics CRISPR-Activation Screen Identifies Epigenetic Regulators of the Zygotic Genome Activation Program.

Cell Syst. 2020-7-22

[3]
A distal enhancer at risk locus 11q13.5 promotes suppression of colitis by T cells.

Nature. 2020-7

[4]
Souporcell: robust clustering of single-cell RNA-seq data by genotype without reference genotypes.

Nat Methods. 2020-5-4

[5]
Combinatorial single-cell CRISPR screens by direct guide RNA capture and targeted sequencing.

Nat Biotechnol. 2020-3-30

[6]
Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression.

Genome Biol. 2019-12-23

[7]
c-Jun overexpression in CAR T cells induces exhaustion resistance.

Nature. 2019-12-4

[8]
Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells.

Cell. 2019-8-22

[9]
Distinct actin cytoskeleton behaviour in primary and immortalised T-cells.

J Cell Sci. 2019-9-4

[10]
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes.

Nat Commun. 2019-4-23

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索